Figure 1: FT-IR spectra and analysis region of nebivolol (a), transdermal patch formulation containing EC and HPMC (b), transdermal patch formulation containing EC and PVP (c)
| Close | |
|
|
|
|
Figure 1: FT-IR spectra and analysis region of nebivolol (a), transdermal patch formulation containing EC and HPMC (b), transdermal patch formulation containing EC and PVP (c)
|
|